Table 3 Clinical, laboratory and angiographic profile of patients with/without GLS ≥ -20%
Variables | GLS > -20% | Total | P* | |
|---|---|---|---|---|
Yes | No | |||
n (%) | n (%) | |||
Disease duration (years)** | 3 ± (3.0–10.0) | 9 (7.0–19.0) | 8 (3.0–16.0) | 0.024 |
C-reactive protein elevated (> 5 mg/dL) | ||||
Yes | 6 (50.0) | 6 (50.0) | 12 (100.0) | 1.000 |
No | 9 (52.9) | 8 (47.1) | 17 (100.0) | |
Type V (angiographic classification) | ||||
Yes | 9 (52.9) | 8 (47.1) | 17 (100.0) | 1.000 |
No | 6 (46.2) | 7 (53.8) | 13 (100.0) | |
Hypertension | ||||
Yes | 10 (50.0) | 10 (50.0) | 20 (100.0) | 1.000 |
No | 5 (50.0) | 5 (50.0) | 10 (100.0) | |
Cardiovascular Domain (ITAS-2010) | ||||
Yes | 5 (62.5) | 3 (37.5) | 8 (100.0) | 0.682 |
No | 10 (45.5) | 12 (54.5) | 22 (100.0) | |